Zika Virus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP
Condition:   Zika Virus Infection Interventions:   Biological: Two MV-ZIKA-RSP vaccinations (high dose);   Biological: Two MV-ZIKA-RSP vaccination (low dose);   Biological: One MV-ZIKA-RSP vaccination (high dose) and one placebo;   Other: Two placebo injection Sponsor:   Themis Bioscience GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2019 Category: Research Source Type: clinical trials